In a welcome move, UiPath stock saw its Relative Strength Rating improve from 61 to 76 on Wednesday.
When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.
IBD's proprietary rating measures market leadership with a 1 (worst) to 99 (best) score. The grade shows how a stock's price movement over the last 52 weeks stacks up against all the other stocks in our database.
Decades of market research reveals that the best stocks tend to have an RS Rating north of 80 in the early stages of their moves. See if UiPath stock can continue to rebound and hit that benchmark.
See How IBD Helps You Make More Money In Stocks
Is UniPath Stock A Buy?
UniPath stock broke out on June 2, but has since pulled back. While now is not an ideal time to invest, see if the computer software stock goes on to offer and clear a proper buy point.
While EPS growth declined in the company's most recent performance report from 200% to 0%, the top line grew 18%, up from 7% in the previous report.
UniPath stock holds the No. 14 rank among its peers in the Computer Software-Enterprise industry group. JFrog and Model N are also among the group's highest-rated stocks.
